Profile
| Metric | Value |
|---|---|
| Full Name | Sotera Health Company |
| Ticker | NASDAQ: SHC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | soterahealth.com |
| Employees | 3,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $19.20 | |
| Price, 1D Change | +2.07% | |
| Market Cap | $5B | |
| - | ||
| PE Ratio | 99.48 | |
| Beta | 1.23 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +4.88% | |
| EPS | $0.16 | |
| EPS, 1Y Change | -13.75% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.16 | |
| EPS Estimate | $0.84 | |
| EPS Est. Change | +438.69% | |
| Revenue | $1.10B | |
| Revenue Estimate | $1.16B | |
| Revenue Est. Change | +5.38% | |
| Current Price | $19.20 | |
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +4.17% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.81 | $0.18 | -77.73% | |
| $0.70 | $0.16 | -77.66% | |
| $0.84 | N/A | +438.69% | |
| $0.94 | N/A | +503.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.04B | $1.05B | +0.78% | |
| $1.10B | $1.10B | -0.06% | |
| $1.16B | N/A | +5.38% | |
| $1.23B | N/A | +11.58% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +43.39% | |
| Price, 3Y | +122.22% | |
| Market Cap, 1Y | +43.71% | |
| Market Cap, 3Y | +123.54% | |
| Revenue, 1Y | +4.88% | |
| Revenue, 3Y | +18.14% | |
| EPS, 1Y | -13.75% | |
| EPS, 3Y | -62.32% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $19.20 | |
| SMA 200 | $14.21 | |
| SMA 200 vs Price | -26.00% | |
| SMA 50 | $16.90 | |
| SMA 50 vs Price | -11.98% | |
| Beta | 1.23 | |
| ATR | $0.44 | |
| 14-Day RSI | 82.68 | |
| 10-Day Volatility | 20.91% | |
| 1-Year Volatility | 44.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.10B | |
| EPS | $0.16 | |
| Gross Profit | $602.30M | |
| Gross Margin | 54.73% | |
| Operating Profit | $297.63M | |
| Operating Margin | 27.05% | |
| Net Income | $44.34M | |
| Net Margin | 4.03% | |
| EBITDA | $442.20M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 5.49 | |
| Current Ratio | 2.75 | |
| Quick Ratio | 2.50 | |
| Interest Coverage | 1.69 | |
| F-Score | 6 | |
| Altman Z-Score | 1.67 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 99.48 | |
| PS Ratio | 4.74 | |
| PB Ratio | 9.91 | |
| EV/EBITDA | 13.96 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $404.91M | |
| Cash & Equivalents | $277.24M | |
| Total Assets | $3.19B | |
| Current Assets | $526.04M | |
| Total Liabilities | $2.78B | |
| Current Liabilities | $191.00M | |
| Total Debt | $2.35B | |
| Short Term Debt | $22.78M | |
| Accounts Payable | $55.10M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $802.82M | |
| Operating Expenses | $304.67M | |
| Cost Of Goods Sold | $498.15M | |
| SG&A | $242.63M | |
| D&A | $163.64M | |
| Interest Expense | $164.69M | |
| Income Tax | $69.48M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $224.16M | |
| CFI | -$179.00M | |
| CFF | -$50.56M | |
| Capex | $179.07M | |
| Free Cash Flow | $45.09M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| William Blair | ||
| BMO Capital | ||
| Piper Sandler | → | |
| JP Morgan | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Goldman Sachs | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with SHC
Data Sources & References
- SHC Official Website soterahealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1822479/000182247925000054/0001822479-25-000054-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1822479/000182247925000015/0001822479-25-000015-index.htm
- SHC Profile on Yahoo Finance finance.yahoo.com/quote/SHC
- SHC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/shc
FAQ
What is the ticker symbol for Sotera Health Company?
The ticker symbol for Sotera Health Company is NASDAQ:SHC
Does Sotera Health Company pay dividends?
No, Sotera Health Company does not pay dividends
What sector is Sotera Health Company in?
Sotera Health Company is in the Healthcare sector
What industry is Sotera Health Company in?
Sotera Health Company is in the Diagnostics & Research industry
What country is Sotera Health Company based in?
Sotera Health Company is headquartered in United States
When did Sotera Health Company go public?
Sotera Health Company initial public offering (IPO) was on November 20, 2020
Is Sotera Health Company in the S&P 500?
No, Sotera Health Company is not included in the S&P 500 index
Is Sotera Health Company in the NASDAQ 100?
No, Sotera Health Company is not included in the NASDAQ 100 index
Is Sotera Health Company in the Dow Jones?
No, Sotera Health Company is not included in the Dow Jones index
When was Sotera Health Company last earnings report?
Sotera Health Company's most recent earnings report was on November 4, 2025
When does Sotera Health Company report earnings?
The next expected earnings date for Sotera Health Company is February 26, 2026